Attention! The information is for reference purposes!
Before taking you should consult with a doctor!
SITE GUIDE ONLY. Not a pharmacy! We do not sell drugs! Nothing!

Description medications: Eritrofosfatid (Erytrophosphatidum)

ERITROFOSFATID (Erytrophosphatidum).

The drug is derived from human red blood cells. It contains glycerophospholipids: phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, fosfatidilmielin.

Yellowish opalescent emulsion; 5 pH 5 - 6, 8.

Glycerophospholipid play an important role in the body's vital processes; As a component of biological membranes, they affect their permeability, are involved in the transmission of nerve impulses in the energy processes.

As eritrofosfatid medication is used as a hemostatic, hemostimulating and desensitizing agent.

Applied in adults with hemorrhagic diathesis, related to violation of thrombus formation, idiopathic thrombocytopenic purpura, hypo-and aplastic anemia, leukemia and others., Disorders of blood coagulation due to deficiency of factors VIII, IX, V, VII, and others. At the same time can be used appropriate gemokoaguliruyuschie facilities.

As antanemic eritrofosfatid prescribed for complex treatment of chronic posthemorrhagic, iron deficiency, aplastic and other anemias.

As a means of desensitizing the drug is used in cases involving, and autoimmune phenomena izogemosensibilizatsii.

Apply eritrofosfatid intramuscularly.

To enhance blood coagulation are administered (to adults) at 150 - 300 mg every 1 - 2 days. Maximal effect was observed after 2 - 3 hours after intramuscular administration. If necessary injections produce 2 - 3 times a day for 2 - 3 days or more. The daily dose is 750 mg.

When administered anemia eritrofosfatid 1 150 mg every 4 - 5 days, only 10 - 15 injections. In anemia with severe bone marrow hematopoiesis, course dose may be increased to 30 - 50 injections.

In the case of severe acute or chronic hypoxia due to profound anemia when the patient requiring transfusion of blood and blood transfusions cause sensitization eritrofosfamid administered intramuscularly for 1 - 2 hours prior to blood transfusion in order to desensitization.

The drug is not suitable for increased blood clotting.

Product: in vials containing 5 ml of the product (emulsion), a package of 10 vials.

Storage: at a temperature of up to + 4 + 8'S in a dark place.